I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 5 studies | 21% ± 3% | |
| plasmablast | 5 studies | 33% ± 19% | |
| ionocyte | 4 studies | 36% ± 7% | |
| transit amplifying cell | 4 studies | 30% ± 5% | |
| erythroblast | 4 studies | 38% ± 19% | |
| basal cell | 4 studies | 26% ± 5% | |
| epithelial cell | 4 studies | 37% ± 13% | |
| erythrocyte | 4 studies | 33% ± 15% | |
| CD4-positive, alpha-beta T cell | 4 studies | 27% ± 4% | |
| CD8-positive, alpha-beta T cell | 4 studies | 23% ± 8% | |
| deuterosomal cell | 3 studies | 21% ± 0% | |
| hematopoietic precursor cell | 3 studies | 27% ± 10% | |
| fibroblast | 3 studies | 17% ± 2% | |
| connective tissue cell | 3 studies | 27% ± 14% | |
| smooth muscle cell | 3 studies | 22% ± 5% | |
| pro-B cell | 3 studies | 28% ± 7% | |
| dendritic cell | 3 studies | 23% ± 6% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 25% ± 7% |
